Childhood Obesity - Prevention of Diabetes Through Changed Eating Patterns
NCT ID: NCT04522921
Last Updated: 2025-08-22
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
211 participants
INTERVENTIONAL
2020-10-01
2032-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Compared to the low-moderate protein diet, the investigators hypothesis that a diet with higher consumption of protein-containing foods will more effectively induce weight loss (a reduction in BMI-SDS) or weight maintenance in children with overweight or obesity, and improve quality of life, and risk factors for type 2 diabetes.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Factors Associated With Changes in Weight-status in Danish School Children With Obesity
NCT06077266
PRE-Pregnancy Weight Loss And the Reducing Effect on CHILDhood Overweight - Copenhagen
NCT05621109
Weight-loss Treatment Program in Children and Adolescents
NCT05790174
"Fit For Kids"-Copenhagen
NCT01660789
Childhood Obesity, Lifestyle Interventions and Weight Development
NCT05345353
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The primary outcome is anthropometry (BMI-SDS, fat mass, fat-free mass). Secondary outcomes are metabolic health and questionnaires investigating quality of life, eating behavior traits, eating habits and eating-related problems i.e., overeating and loss of control eating.
The children will be measured at baseline, 10-weeks and at a 52-weeks follow-up visit.
Furthermore, participants will be invited to follow-up visits 3 years, 5 years, 7 years and 10 years, respectively.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
FACTORIAL
2. Control group (CG): Current weight-loss diet (15E%/day protein) for the 10 weeks they attend the camp.
2\) Intervention group (IG): A higher protein diet (25E%/day) for the 10 weeks they attend the camp.
PREVENTION
DOUBLE
The investigator has no knowledge of or influence on how participants are divided into different groups. Participants are assigned groups by the camp staff.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SARS CoV-group
This group should have been the control group. However, due to the COVID19 lockdown of the camps for 5 five weeks, with no control of diet and physical activity, this group could not act as control group. Therefore, this group has been excluded from longitudinal analyses.
Diet with a lower amount of protein (15E% per day)
In a caloric restricted and increased physical activity setting, the participants will be served a low-moderate protein (15E%/day) diet.
Control Group (CG)
Current weight-loss diet (15E%/day protein) for the 10 weeks they attend the camp. Increased follow-up contact after camp.
Increased follow-up contact after the 10-week intervention
Both the control-group and the intervention-group were offered an increased follow-up contact after camp.
Diet with a lower amount of protein (15E% per day)
In a caloric restricted and increased physical activity setting, the participants will be served a low-moderate protein (15E%/day) diet.
Intervention group (IG)
A higher protein diet (25E%/day) for the 10 weeks they attend the camp. Increased follow-up contact after camp.
Diet with a higher amount of protein (25E% per day)
In a caloric restricted and increased physical activity setting, the participants will be served a higher protein (25E%/day) diet.
Increased follow-up contact after the 10-week intervention
Both the control-group and the intervention-group were offered an increased follow-up contact after camp.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diet with a higher amount of protein (25E% per day)
In a caloric restricted and increased physical activity setting, the participants will be served a higher protein (25E%/day) diet.
Increased follow-up contact after the 10-week intervention
Both the control-group and the intervention-group were offered an increased follow-up contact after camp.
Diet with a lower amount of protein (15E% per day)
In a caloric restricted and increased physical activity setting, the participants will be served a low-moderate protein (15E%/day) diet.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The child is between 7 and 14 years of age (inclusive) while attending camp.
* At least one parent/guardian submit written and oral consent to participate with his/her child.
* Parent/legal guardian has submitted oral and written consent to participation of their child. In case of shared custody both parents must submit written and oral consent before their child can participate in the trial.
Exclusion Criteria
* The child or parent/guardian participate in another clinical trial or plan to do so in the near future.
* The parent/guardian do not understand the written informed consent.
* The child or parent/guardian are unwilling to or unable to comply with the study protocol and instruction given by the study staff.
7 Years
14 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Aarhus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jens M Bruun, Professor
Role: PRINCIPAL_INVESTIGATOR
Aarhus University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Weight Loss Camp Hobro
Hobro, , Denmark
Weight Loss Camp Fjordmark
Kruså, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Jakobsen DD, Brader L, Bruun JM. Effect of a higher protein diet and lifestyle camp intervention on childhood obesity (The COPE study): results from a nonrandomized controlled trail with 52-weeks follow-up. Eur J Nutr. 2024 Sep;63(6):2173-2184. doi: 10.1007/s00394-024-03420-z. Epub 2024 May 9.
Jakobsen DD, Jarvholm K, Brader L, Bruun JM. Long-term changes in eating-related problems and quality of life in children with overweight and obesity attending a 10-week lifestyle camp. Obes Res Clin Pract. 2024 May-Jun;18(3):209-215. doi: 10.1016/j.orcp.2024.04.002. Epub 2024 May 4.
Pauls DD, Clausen L, Bruun JM. Eating behavior profiles in children following a 10-week lifestyle camp due to overweight/obesity and low quality of life: A latent profile analysis on eating behavior. Eat Behav. 2025 Apr;57:101971. doi: 10.1016/j.eatbeh.2025.101971. Epub 2025 Mar 24.
Aagaard I, Jakobsen DD, Bruun JM. Association between quality of life and emotional overeating - a cross-sectional study in Danish children attending a multicomponent lifestyle camp. Eur J Pediatr. 2023 Dec;182(12):5493-5499. doi: 10.1007/s00431-023-05206-7. Epub 2023 Sep 30.
Orry S, Dalstrup Jakobsen D, Kristensen NM, Meldgaard Bruun J. Uric acid and sCD163 as biomarkers for metabolic dysfunction and MAFLD in children and adolescents with overweight and obesity. J Pediatr Endocrinol Metab. 2023 Jun 8;36(7):643-649. doi: 10.1515/jpem-2023-0228. Print 2023 Jul 26.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
The COPE-study
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.